article Open AccessTop 1% cited

m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells

Cell stem cell · 2014 · Vol. 15(6) · pp. 707–719

Pedro J. Batista✉(Stanford University)Benoit Molinié(Massachusetts General Hospital)Jinkai Wang(University of California, Los Angeles)Kun Qu(Stanford University)Jiajing Zhang(Stanford University)Lingjie Li(Howard Hughes Medical Institute)Donna M. Bouley(Stanford University)Ernesto Lujan(Stanford University)Bahareh Haddad(Stanford University)K. Daneshvar(Massachusetts General Hospital)Ava C. Carter(Howard Hughes Medical Institute)Ryan A. Flynn(Howard Hughes Medical Institute)Chan Zhou(Massachusetts General Hospital)Kok-Seong Lim(Massachusetts Institute of Technology)Peter C. Dedon(Massachusetts Institute of Technology)Marius Wernig(Stanford University)Alan C. Mullen(Harvard Stem Cell Institute)Yi Xing(University of California, Los Angeles)Cosmas Giallourakis(Harvard Stem Cell Institute)Howard Y. Chang(Stanford University)

View via DOI Full-text PDF

RNA modifications and cancer HVDC Systems and Fault Protection Cardiac Structural Anomalies and RepairBiologyEmbryonic stem cellCell biologyStem cellRNACell fate determinationTransition (genetics)CellGeneticsTranscription factor

MeSH terms

Nanog Homeobox ProteinAdenineAnimalsBase SequenceCell DifferentiationCell LineFemaleHumansMethyltransferasesMolecular Sequence DataMutationRNA Processing, Post-TranscriptionalMice, SCIDConserved SequenceHomeodomain Proteins

Citations

1,358

FWCI

27.62

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches